Womb for sale debate surfaces in Nepal
By Times of India,
The Times of India [Nepal]
| 03. 08. 2011
Almost nine years after India's Supreme Court gave the legal nod to commercial surrogacy, the issue has finally surfaced in Nepal after a disgruntled wife went to court to prevent her husband from bequeathing his property to his daughter by a surrogate mother.
Sambhavi Rana, who comes from an upper class family in Kathmandu, and her mother-in-law Vidya Rana, went to Supreme Court to stop the former's husband, Ujjwal Rana, from bequeathing the couple's property to his three-year-old daughter Bina. Bina had been conceived by a commercial surrogate mother, Ayushma Nagarkoti, with whom Rana had signed a formal contract, undertaking to pay maintenance and medical costs for her for two years and the woman had agreed to hand over the child when she was two.
Though Rana had also notified the chief district officer, saying his wife, who was incapable of giving birth, had agreed to the contract, the wife challenged it in court, saying she was kept in the dark. She also challenged his claim that she could not conceive, accusing him of mental and other forms of cruelty...
Related Articles
By Nick Paul Taylor, BioSpace | 03.14.2024
A U.K. watchdog balked at the cost-effectiveness of Vertex Pharmaceuticals’ CRISPR-based sickle cell disease therapy Thursday, recommending against funding the treatment unless uncertainties can be cleared up satisfactorily.
The U.K. became the first country to authorize Vertex’s Casgevy (exagamglogene...
By Anna Collinson, Maryam Ahmed and Bella McShane, BBC | 03.12.2024
Women who freeze their eggs are being misled by some UK clinics about their chances of having a baby, a fertility charity says.
The Fertility Network was reacting to BBC analysis that found 41% of clinics offering the service privately...
By Isabelle Bartram, Guest Contributor
| 03.13.2024
Note: This article was originally published in February 2024 in issue 268 of the German-language journal Der Gen-ethische Informationsdienst (GID). It is also part of an English-language dossier on Heritable Human Genome Editing published at the same time. Minor edits have been made.
Calls for German embryo research
Pressure on the German Embryo Protection Act is growing. The scientific community is launching a renewed attack on the controversial law and demands access to embryos for so-called high-ranking research objectives. "Germline therapies" are...
By Andrew Joseph, STAT | 02.22.2024
In the years leading up to Russia’s invasion, Ukraine had become a burgeoning hub of clinical trials, particularly in oncology. The war put a hold on the vast majority of those studies.
But as the country marks two years this...